Comparıson Of The Effects Of Perıcapsulary Nerve Group Block (Peng Block) And Lumbar Erector Spına Plan Block (Lesp Block) On Postoperatıve Opıoıd Consumptıon

The aim is to demonstrate that lumbar ESP block provides more effective postoperative analgesia than PENG block in geriatric patients with hip fractures, and reduces postoperative opioid consumption more than PENG block

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Pengblock Hipfracture Lumbar Erector Spinae Plane Block over65years

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with hip fractures
over 65 years old

Exclusion criteria

long-term surgery
Patients who do not want regional anesthesia
bleeding disorder disease
wound in the operation area

Treatment and study plan

Postoperative pain assessment of patients who underwent block

Procedure

Postoperative pain assessment of patients who underwent block

Primary outcomes

postoperative pain

Time frame: 6 month

To evaluate postoperative pain after two different block applications in patients undergoing hip fracture surgery.Evaluation of patients' postoperative 30th minute, 2nd hour, 6th hour, 12th hour and 24th hour verbal analog scores.To examine the total fentanyl consumption, acetaminophen consumption, and nonsteroidal anti-inflammatory drug consumption of patients in the postoperative 24 hours.

Sponsors and collaborators

Lead sponsor

Sakarya University

Other

Registry information

Official study title

Comparison of the Effects of Pericapsular Nerve Group Block (Peng Block) and Lumbar Erector Spinae Plane Block (Lesp Block) on Postoperative Opioid Consumption in Geriatric Patients Undergoing Hip Fracture Surgery

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2026
First posted: May 29, 2025
Registry last updated: May 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed